The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson's Disease: Focus on Astrocytes

被引:286
作者
Niranjan, Rituraj [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Div Gastroenterol & Liver Dis, Cleveland, OH 44106 USA
关键词
Parkinson's disease; Inflammatory mediators; Oxidative stress; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STIMULATED RAT ASTROCYTOMA; TNF-ALPHA; DOPAMINERGIC NEURODEGENERATION; GENE-EXPRESSION; MITOCHONDRIAL DYSFUNCTION; INDUCED NEUROINFLAMMATION; INDUCED NEUROTOXICITY; ALZHEIMER-DISEASE; GLIAL-CELLS;
D O I
10.1007/s12035-013-8483-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuroinflammation plays a key role in the pathogenesis of Parkinson's disease (PD). Epidemiologic, animal, human, and therapeutic studies support the role of oxidative stress and inflammatory cascade in initiation and progression of PD. In Parkinson's disease pathophysiology, activated glia affects neuronal injury and death through production of neurotoxic factors like glutamate, S100B, tumor necrosis factor alpha (TNF-alpha), prostaglandins, and reactive oxygen and nitrogen species. As disease progresses, inflammatory secretions engage neighboring cells, including astrocytes and endothelial cells, resulting in a vicious cycle of autocrine and paracrine amplification of inflammation leading to neurodegeneration. The exact mechanism of these inflammatory mediators in the disease progression is still poorly understood. In this review, we highlight and discuss the mechanisms of oxidative stress and inflammatory mediators by which they contribute to the disease progression. Particularly, we focus on the altered role of astroglial cells that presumably initiate and execute dopaminergic neurodegeneration in PD. In conclusion, we focus on the molecular mechanism of neurodegeneration, which contributes to the basic understanding of the role of neuroinflammation in PD pathophysiology.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 108 条
[1]  
Ahmed M, 2006, J RHEUMATOL, V33, P2344
[2]   Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice [J].
Akundi, Ravi S. ;
Huang, Zhenyu ;
Eason, Joshua ;
Pandya, Jignesh D. ;
Zhi, Lianteng ;
Cass, Wayne A. ;
Sullivan, Patrick G. ;
Bueeler, Hansruedi .
PLOS ONE, 2011, 6 (01)
[3]   Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole [J].
Albrecht, Stefan ;
Buerger, Erich .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) :2977-2987
[4]   The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease [J].
Allan, S. M. ;
Pinteaux, E. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (05) :293-302
[5]   TNF-α expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior [J].
Aloe, L ;
Fiore, M .
NEUROSCIENCE LETTERS, 1997, 238 (1-2) :65-68
[6]   Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice [J].
Aoki, Eriko ;
Yano, Ryohei ;
Yokoyama, Hironori ;
Kato, Hiroyuki ;
Araki, Tsutomu .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 86 (01) :57-64
[7]   Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease [J].
Asanuma, Masato ;
Miyazaki, Ikuko .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (14) :1428-1434
[8]  
BALASINGAM V, 1994, J NEUROSCI, V14, P846
[9]  
Beal MF, 2003, ANN NY ACAD SCI, V991, P120
[10]   IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease [J].
Bessler, H ;
Djaldetti, R ;
Salman, H ;
Bergman, M ;
Djaldetti, M .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :141-145